| Geetanjali Jain, MSN, DNP, FNP-BC | |
|
11800 Sunrise Valley Dr Ste 700, Reston, VA 20191-5315 | |
| (703) 834-1473 | |
| (703) 318-7463 |
| Full Name | Geetanjali Jain |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 11800 Sunrise Valley Dr Ste 700, Reston, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124653589 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 0024179589 (Virginia) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 0024179589 (Virginia) | Primary |
| Entity Name | Tgvpc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093838740 PECOS PAC ID: 8224198122 Enrollment ID: O20081121000675 |
News Archive
Takeda Pharmaceutical Company Limited announced today that it has voluntarily decided to end the development program for orteronel (TAK-700) for prostate cancer. The decision follows the results of two Phase 3 clinical trials in metastatic, castration resistant prostate cancer (mCRPC).
A team of scientists from the USA and Germany has recently studied the evolution of SARS-CoV-2 in a representative set of sequences from the USA collected between 2020 and 2021. The findings reveal that the viral genome has accumulated multiple mutations over time with only occasional loss of mutation. The main driving forces behind such genetic variations include widespread infection and superspreader events.
Hair ethyl glucuronide can be reliably used to detect moderate levels of alcohol consumption in the previous 28 days in patients with liver disease, show study results.
According to the American consumer group Campaign for Safe Cosmetics, tests on 33 brand-name lipsticks, some of them expensive luxury brands, have found that 61 percent of them contained detectable levels of lead.
SHL Telemedicine Ltd., a leading provider and developer of advanced personal telemedicine solutions, today announced that it has signed a distribution agreement for its innovative smartheart device with USCI Holdings, Inc., of Japan.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Geetanjali Jain, MSN, DNP, FNP-BC Po Box 37174, Baltimore, MD 21297-3174 Ph: (571) 423-5699 | Geetanjali Jain, MSN, DNP, FNP-BC 11800 Sunrise Valley Dr Ste 700, Reston, VA 20191-5315 Ph: (703) 834-1473 |
News Archive
Takeda Pharmaceutical Company Limited announced today that it has voluntarily decided to end the development program for orteronel (TAK-700) for prostate cancer. The decision follows the results of two Phase 3 clinical trials in metastatic, castration resistant prostate cancer (mCRPC).
A team of scientists from the USA and Germany has recently studied the evolution of SARS-CoV-2 in a representative set of sequences from the USA collected between 2020 and 2021. The findings reveal that the viral genome has accumulated multiple mutations over time with only occasional loss of mutation. The main driving forces behind such genetic variations include widespread infection and superspreader events.
Hair ethyl glucuronide can be reliably used to detect moderate levels of alcohol consumption in the previous 28 days in patients with liver disease, show study results.
According to the American consumer group Campaign for Safe Cosmetics, tests on 33 brand-name lipsticks, some of them expensive luxury brands, have found that 61 percent of them contained detectable levels of lead.
SHL Telemedicine Ltd., a leading provider and developer of advanced personal telemedicine solutions, today announced that it has signed a distribution agreement for its innovative smartheart device with USCI Holdings, Inc., of Japan.
› Verified 8 days ago